Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Omori, Y.
Right arrow Articles by Yamasaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omori, Y.
Right arrow Articles by Yamasaki, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 10, 1913-1918, October 1999
© 1999 Oxford University Press


Cancer Biology

Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails

Yasufumi Omori and Hiroshi Yamasaki1

Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, 150 cours Albert-Thomas, 69372 Lyon Cedex 08, France

Our laboratory has previously reported that transfection of a connexin26 (Cx26) gene, but not connexin40 nor connexin43 (Cx43), into HeLa cells expressing no detectable level of connexins suppressed the tumorigenic phenotype of the HeLa cells both in vitro and in vivo, although all of these connexins induced gap junctional intercellular communication in HeLa cells to a similar extent. The most remarkable structural difference between connexin proteins is the length of the C-terminal cytoplasmic tail, Cx26 having almost no tail, while Cx43 and connexin32 (Cx32) have long and intermediate ones, respectively. When Cx32 and Cx43 lose their C-terminal tails, they seem to resemble Cx26 in structure. To examine whether such truncated connexins become tumor suppressive in HeLa cells, we introduced a stop codon into each of the Cx32 and Cx43 cDNAs to remove their C-terminal tails and transfected these constructs ({Delta}Cx) into HeLa cells. Both {Delta}Cx cDNAs induced GJIC as efficiently as the wild-type counterparts. Although none of the truncated connexins affected proliferation rate, the truncated Cx32 and Cx43 proteins suppressed anchorage-independent cell growth in soft agar. Furthermore, when the transfectants were injected into the backs of nude mice, tumor appearance was delayed by 7 days in animals given cells expressing truncated connexins, i.e. tumors became detectable on days 11 and 18 after injection of vector and {Delta}Cx transfectants, respectively. Although throughout these experiments the truncated connexins did not completely eliminate the tumorigenicity of HeLa cells, as Cx26 did, it was evident that deletion of the C-terminal tails gave both Cx32 and Cx43 a capacity for negative growth control, suggesting that the C-terminal tails of these two connexins function as a regulatory region for connexin-mediated growth control in HeLa cells.

Abbreviations: Cx26, connexin26; Cx32, connexin32; Cx43, connexin43; FCS, fetal calf serum; GJIC, gap junctional intercellular communication; LPA, lysophosphatidic acid.

1 To whom correspondence should be addressed Email: yamasaki{at}iarc.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
D. Y. Rhee, X.-Q. Zhao, R. J. B. Francis, G. Y. Huang, J. D. Mably, and C. W. Lo
Connexin 43 regulates epicardial cell polarity and migration in coronary vascular development
Development, September 15, 2009; 136(18): 3185 - 3193.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
H. OZAWA, H. MUTAI, T. MATSUNAGA, Y. TOKUMARU, M. FUJII, K. SAKAMOTO, T. TOMITA, and K. OGAWA
Promoted Cell Proliferation by Connexin 30 Gene Transfection to Head-and-Neck Cancer Cell Line
Anticancer Res, June 1, 2009; 29(6): 1981 - 1985.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. De Vuyst, E. Decrock, M. De Bock, H. Yamasaki, C. C. Naus, W. H. Evans, and L. Leybaert
Connexin Hemichannels and Gap Junction Channels Are Differentially Influenced by Lipopolysaccharide and Basic Fibroblast Growth Factor
Mol. Biol. Cell, January 1, 2007; 18(1): 34 - 46.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. N.G Giepmans
Gap junctions and connexin-interacting proteins
Cardiovasc Res, May 1, 2004; 62(2): 233 - 245.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. K. Chipman, A. Mally, and G. O. Edwards
Disruption of Gap Junctions in Toxicity and Carcinogenicity
Toxicol. Sci., February 1, 2003; 71(2): 146 - 153.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Muramatsu, M. Iwai, T. Morikawa, S. Tanaka, T. Mori, Y. Harada, and T. Okanoue
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells
Carcinogenesis, February 1, 2002; 23(2): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Yano, F.-J. Hernandez-Blazquez, Y. Omori, and H. Yamasaki
Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32
Carcinogenesis, October 1, 2001; 22(10): 1593 - 1600.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.